ESLA (Estrella Immunopharma) Buyback Yield %: -25.19 (As of Aug. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ESLA Estrella Immunopharma Inc ESLA
12 GF Score
Price $0.71
! 1 Warning Sign
View Full Analysis

What is Estrella Immunopharma Buyback Yield %?

Estrella Immunopharma ESLA -1.11% 12 Buyback Yield % is -25.19 as of Aug. 28, 2026. GuruFocus rates ESLA with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 701 Biotechnology companies, Estrella Immunopharma ranks worse than 70.33% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Estrella Immunopharma's current buyback yield was -25.19%.

Estrella Immunopharma Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Estrella Immunopharma's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Estrella Immunopharma Buyback Yield % Chart

Estrella Immunopharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Dec25
Buyback Yield %
0.00 0.00 0.00 0.93 -4.00

Estrella Immunopharma Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.11 -2.89 -4.00 -20.67 -17.87

ESLA vs LITS, NNVC, LTRN: Buyback Yield % Comparison

For the Biotechnology subindustry, Estrella Immunopharma's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Estrella Immunopharma Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Estrella Immunopharma's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Estrella Immunopharma's Buyback Yield % falls into.


ESLA
12GF Score
Estrella Immunopharma Inc ESLA
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Estrella Immunopharma Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Estrella Immunopharma's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.029 + 2.4) / 59.23476
=-4.00%

Estrella Immunopharma's annualized Buyback Yield for the quarter that ended in Jun. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 8) / 44.75536
=-17.87%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -25.19 mean?
Estrella Immunopharma (ESLA) has a Buyback Yield % of -25.19 as of Aug. 28, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Estrella Immunopharma and its competitors. According to the industry distribution chart, Estrella Immunopharma ranks #493 out of 701 companies in the Biotechnology industry, placing it in the top 70.3%.
Is Estrella Immunopharma's Buyback Yield % too high?
Estrella Immunopharma's current Buyback Yield % is -25.19. Based on the distribution chart, Estrella Immunopharma ranks #493 out of 701 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Estrella Immunopharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Estrella Immunopharma's Buyback Yield % compare to LITS and NNVC?
According to the Biotechnology industry distribution chart, Estrella Immunopharma ranks #493 out of 701 companies for Buyback Yield %. This places Estrella Immunopharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Estrella Immunopharma and its competitors. Estrella Immunopharma's current Buyback Yield % is -25.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Estrella Immunopharma stock overvalued right now?
Estrella Immunopharma (ESLA) has a current Buyback Yield % of -25.19. The current Buyback Yield % is -25.19. Estrella Immunopharma's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Estrella Immunopharma (ESLA), the current Buyback Yield % is -25.19 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Estrella Immunopharma Business Description

Address 5858 Horton Street, Suite 370, Emeryville, CA, USA, 94608
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
12GF Score

Get the complete analysis for ESLA

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.71
Price